142 related articles for article (PubMed ID: 2895030)
1. Serum lysyl oxidase activity in patients with various liver diseases.
Sakamoto M; Murawaki Y; Hirayama C
Gastroenterol Jpn; 1987 Dec; 22(6):730-6. PubMed ID: 2895030
[TBL] [Abstract][Full Text] [Related]
2. Increased lysyl oxidase activity in culture medium of nonparenchymal cells from fibrotic livers.
Konishi A; Iguchi H; Ochi J; Kinoshita R; Miura K; Uchino H
Gastroenterology; 1985 Oct; 89(4):709-15. PubMed ID: 2863189
[TBL] [Abstract][Full Text] [Related]
3. [Plasma lysyl oxidase activity in human liver disease].
Suzuki H; Suzuki M; Akiyama S; Kasai N; Koike Y; Kono M; Okabe K
Nihon Shokakibyo Gakkai Zasshi; 1984 Nov; 81(11):2775-9. PubMed ID: 6151604
[No Abstract] [Full Text] [Related]
4. Serum lysyl oxidase activity in chronic liver disease in comparison with serum levels of prolyl hydroxylase and laminin.
Murawaki Y; Kusakabe Y; Hirayama C
Hepatology; 1991 Dec; 14(6):1167-73. PubMed ID: 1683640
[TBL] [Abstract][Full Text] [Related]
5. Lysyl oxidase and collagenase in experimental acute and chronic liver injury.
Carter EA; McCarron MJ; Alpert E; Isselbacher KJ
Gastroenterology; 1982 Mar; 82(3):526-34. PubMed ID: 6119272
[TBL] [Abstract][Full Text] [Related]
6. Synthesis of lysyl oxidase in experimental hepatic fibrosis.
Wakasaki H; Ooshima A
Biochem Biophys Res Commun; 1990 Feb; 166(3):1201-4. PubMed ID: 1689573
[TBL] [Abstract][Full Text] [Related]
7. The activity of lysyl oxidase in experimental hepatic fibrosis.
McPhie JL
Hepatogastroenterology; 1981 Oct; 28(5):240-1. PubMed ID: 6124494
[TBL] [Abstract][Full Text] [Related]
8. Biochemical and immunochemical study of lysyl oxidase in experimental hepatic fibrosis in the rat.
Siegel RC; Chen KH; Greenspan JS; Aguiar JM
Proc Natl Acad Sci U S A; 1978 Jun; 75(6):2945-9. PubMed ID: 26918
[TBL] [Abstract][Full Text] [Related]
9. The clinical significance of slightly to moderately increased liver transaminase values in asymptomatic patients.
Mathiesen UL; Franzén LE; Frydén A; Foberg U; Bodemar G
Scand J Gastroenterol; 1999 Jan; 34(1):85-91. PubMed ID: 10048738
[TBL] [Abstract][Full Text] [Related]
10. Abnormal deposition of collagen around hepatocytes in Wilson's disease is associated with hepatocyte specific expression of lysyl oxidase and lysyl oxidase like protein-2.
Vadasz Z; Kessler O; Akiri G; Gengrinovitch S; Kagan HM; Baruch Y; Izhak OB; Neufeld G
J Hepatol; 2005 Sep; 43(3):499-507. PubMed ID: 16023247
[TBL] [Abstract][Full Text] [Related]
11. Hepatic collagen content and lysyl oxidase activity in rats fed a low protein-ethanol diet.
Shiota G; Murawaki Y; Hirayama C
Res Commun Chem Pathol Pharmacol; 1987 Oct; 58(1):115-27. PubMed ID: 2893439
[TBL] [Abstract][Full Text] [Related]
12. Lysyl oxidase activity in human normal skins and postburn scars.
Hayakawa T; Hino N; Fuyamada H; Nagatsu T; Aoyama H
Clin Chim Acta; 1976 Sep; 71(2):245-50. PubMed ID: 9213
[TBL] [Abstract][Full Text] [Related]
13. Lysyl oxidase: mechanism, regulation and relationship to liver fibrosis.
Kagan HM
Pathol Res Pract; 1994 Oct; 190(9-10):910-9. PubMed ID: 7899140
[TBL] [Abstract][Full Text] [Related]
14. Serum isoamylases in liver diseases.
Tsianos EB; Jalali MT; Gowenlock AH; Braganza JM
Hepatogastroenterology; 1986 Dec; 33(6):247-9. PubMed ID: 3804182
[TBL] [Abstract][Full Text] [Related]
15. gamma-Glutamyl transpeptidase activity in liver disease: serum elevation is independent of hepatic GGTP activity.
Selinger MJ; Matloff DS; Kaplan MM
Clin Chim Acta; 1982 Nov; 125(3):283-90. PubMed ID: 6129080
[TBL] [Abstract][Full Text] [Related]
16. Lysyl oxidase activity in lungs of copper-deficient hamsters.
Soskel NT; Sandberg LB
Connect Tissue Res; 1985; 13(2):127-33. PubMed ID: 2859144
[TBL] [Abstract][Full Text] [Related]
17. Hepatic prolyl hydroxylase activity in human liver disease.
McPhie JL
Hepatogastroenterology; 1980 Aug; 27(4):277-82. PubMed ID: 6259037
[TBL] [Abstract][Full Text] [Related]
18. [Activities of glutathione enzymes in liver biopsy specimens in chronic lesions of hepatocytes].
Matiushin BN; Loginov AS; Tkachev VD
Klin Lab Diagn; 1998 Apr; (4):16-8. PubMed ID: 9621574
[TBL] [Abstract][Full Text] [Related]
19. [Serum cathepsin activity in chronic liver diseases].
Kucharz EJ; Kucharz M
Z Gesamte Inn Med; 1986 Nov; 41(22):636-8. PubMed ID: 3031888
[TBL] [Abstract][Full Text] [Related]
20. Simtuzumab Is Ineffective for Patients With Bridging Fibrosis or Compensated Cirrhosis Caused by Nonalcoholic Steatohepatitis.
Harrison SA; Abdelmalek MF; Caldwell S; Shiffman ML; Diehl AM; Ghalib R; Lawitz EJ; Rockey DC; Schall RA; Jia C; McColgan BJ; McHutchison JG; Subramanian GM; Myers RP; Younossi Z; Ratziu V; Muir AJ; Afdhal NH; Goodman Z; Bosch J; Sanyal AJ;
Gastroenterology; 2018 Oct; 155(4):1140-1153. PubMed ID: 29990488
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
